Risperidone is a second-generation antipsychotic, blocking dopamine D2 and serotonin receptors. It is licensed for schizophrenia, for mania in bipolar disorder, and - uniquely among antipsychotics in the UK - for short-term treatment of persistent aggression in Alzheimer's dementia. It causes less weight gain than olanzapine and fewer movement problems than older drugs, but it raises prolactin more than almost any other antipsychotic, and those effects are the ones people are rarely asked about.
Follow the plan your prescriber gave you. This guide contains no doses. Do not stop it abruptly.
The prolactin effect
Dopamine normally suppresses prolactin release from the pituitary. Blocking dopamine removes that brake, and prolactin rises.
The consequences are:
- In women - irregular or absent periods, breast enlargement and tenderness, and milk production unrelated to pregnancy
- In men - breast enlargement, breast tenderness, and sometimes milk production
- In both - reduced libido, sexual dysfunction and infertility
- Long-term - reduced bone density, since low oestrogen and testosterone follow from high prolactin
These are common, they are distressing, and they are systematically under-reported because nobody asks and people do not volunteer them.
If any of these have appeared since starting risperidone, say so. Prolactin can be measured, and options include dose reduction or switching to an antipsychotic with less prolactin effect - aripiprazole in particular lowers it.
See antipsychotics and medicines and bone health.
Movement effects are dose-related
At low doses risperidone behaves like a second-generation drug, with few movement problems. As the dose rises, dopamine blockade increases and it starts to behave more like an older antipsychotic.
Stiffness, tremor, slowed movement and akathisia - an intense inner restlessness frequently mistaken for anxiety - all become more likely at higher doses.
Report restlessness, stiffness, tremor, or any involuntary movement of the face or tongue, which can indicate tardive dyskinesia and may be permanent.
Seek urgent help for high fever with muscle rigidity, confusion and sweating - neuroleptic malignant syndrome.
Metabolic effects
Risperidone causes less weight gain and metabolic disturbance than olanzapine, but more than aripiprazole - it sits in the middle of the class.
Weight, waist circumference, blood pressure, glucose and lipids should be monitored before starting, through the first year and then annually.
See olanzapine and monitoring long-term medicines.
The depot injection
Long-acting injectable risperidone is given every two weeks, with newer formulations lasting a month or longer.
Depot treatment substantially reduces relapse in people who find daily tablets difficult, and that is its purpose rather than convenience alone.
With the two-weekly form, oral treatment continues for the first few weeks while levels build - stopping tablets too early is a recognised cause of relapse.
Missing an injection matters, and clinics plan around it. Ring before the date rather than after.
In dementia
Risperidone has a short-term licence for persistent aggression in moderate to severe Alzheimer's dementia where non-drug approaches have failed and there is risk of harm.
The licence is for up to six weeks, and that limit exists because antipsychotics raise the risk of stroke and death in dementia.
If a relative with dementia has been on an antipsychotic for months without review, that is worth questioning. Non-drug approaches - addressing pain, infection, constipation, boredom and environment - come first and are frequently skipped.
See donepezil and memantine, which is a safer option for agitation.
Other effects
Dizziness on standing, particularly early, since risperidone blocks alpha receptors. Get up slowly.
Sedation, though less than with olanzapine or quetiapine. Do not drive until you know how it affects you.
It prolongs the QT interval - see medicines that affect your heart rhythm.
Report fever with sore throat or mouth ulcers.
Orodispersible tablets and liquid
Risperidone comes as an orodispersible tablet that dissolves on the tongue, and as a liquid. Both are useful where swallowing is difficult, and the orodispersible form is sometimes preferred where adherence is uncertain.
The liquid should not be mixed with tea or cola, which can affect it. Water, orange juice or coffee are generally fine - check your product.
Stopping
Stopping abruptly causes discontinuation symptoms and, more importantly, a substantial risk of relapse. Any reduction should be gradual and planned.
Paroxetine and fluoxetine raise risperidone levels by inhibiting CYP2D6 - see paroxetine. Carbamazepine lowers them.
Paliperidone
Paliperidone is the active metabolite of risperidone, available as a modified-release tablet and as monthly and three-monthly depot injections.
It behaves similarly, including on prolactin, but it is cleared by the kidneys rather than the liver, which occasionally decides the choice. The longer depot intervals suit people for whom attending every two weeks is the obstacle, and switching between the two is a specialist decision with a conversion rather than a straight swap.
If you are struggling, Samaritans are free on 116 123, or you can text SHOUT to 85258.
More on what medicines are prescribed for in the Conditions section, including Aripiprazole: A Different Kind of Antipsychotic.